{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:08:17Z","timestamp":1791101297635,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.arcped.2014.01.005","type":"journal-article","created":{"date-parts":[[2014,3,15]],"date-time":"2014-03-15T18:15:47Z","timestamp":1394907347000},"page":"404-414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Dr\u00e9panocytose et atteinte vasculaire c\u00e9r\u00e9brale chez l\u2019enfant"],"prefix":"10.1016","volume":"21","author":[{"given":"M.","family":"Kossorotoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Grevent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"de Montalembert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcped.2014.01.005_bib0005","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1474-4422(06)70469-0","article-title":"Pathophysiology and treatment of stroke in sickle-cell disease: present and future","volume":"5","author":"Switzer","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.arcped.2014.01.005_bib0010","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1365-2141.2005.05701.x","article-title":"Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality","volume":"130","author":"Kato","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.arcped.2014.01.005_bib0015","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00062752-200203000-00003","article-title":"Sickle cell vaso-occlusion: multistep and multicellular paradigm","volume":"9","author":"Frenette","year":"2002","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.arcped.2014.01.005_bib0020","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1056\/NEJMp058274","article-title":"Preventing stroke in sickle cell anemia","volume":"353","author":"Platt","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcped.2014.01.005_bib0025","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1182\/blood-2007-04-081703","article-title":"Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease","volume":"111","author":"Morris","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.arcped.2014.01.005_bib0030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1182\/asheducation-2007.1.91","article-title":"Hypercoagulability in sickle cell disease: new approaches to an old problem","volume":"1","author":"Ataga","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.arcped.2014.01.005_bib0035","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/01.ATV.0000220374.00602.a2","article-title":"Biologically active CD40\u00a0ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation","volume":"26","author":"Lee","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.arcped.2014.01.005_bib0040","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","article-title":"Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Gorelick","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.arcped.2014.01.005_bib0045","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/s-0031-1278326","article-title":"Atherosclerosis in sickle cell disease \u2013 a review","volume":"18","author":"Elsharawy","year":"2009","journal-title":"Int J Angiol"},{"key":"10.1016\/j.arcped.2014.01.005_bib0050","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.3324\/haematol.11253","article-title":"Endothelial-dependent vasodilation is impaired in children with sickle cell disease","volume":"92","author":"de Montalembert","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.arcped.2014.01.005_bib0055","first-page":"288","article-title":"Cerebrovascular accidents in sickle cell disease: rates and risk factors","volume":"91","author":"Ohene-Frempong","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.arcped.2014.01.005_bib0060","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1161\/STROKEAHA.108.189696","article-title":"Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young","volume":"39","author":"Roach","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.arcped.2014.01.005_bib0065","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1182\/blood-2010-06-293514","article-title":"Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort","volume":"117","author":"Bernaudin","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.arcped.2014.01.005_bib0070","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1182\/blood.V99.8.3014","article-title":"Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease","volume":"99","author":"Pegelow","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.arcped.2014.01.005_bib0075","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1212\/WNL.56.8.1109","article-title":"Poor school and cognitive functioning with silent cerebral infarcts and sickle cell disease","volume":"56","author":"Schatz","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.arcped.2014.01.005_bib0080","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/088307380001500510","article-title":"Multicenter prospective study of children with sickle cell disease: radiographic and psychometric correlation","volume":"15","author":"Bernaudin","year":"2000","journal-title":"J Child Neurol"},{"key":"10.1016\/j.arcped.2014.01.005_bib0085","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1182\/blood.V99.9.3144","article-title":"Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events","volume":"99","author":"Dobson","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.arcped.2014.01.005_bib0090","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.surneu.2008.03.044","article-title":"Intracranial aneurysms in sickle cell patients: report of 2\u00a0cases and review of the literature","volume":"72","author":"Brand\u00e3o","year":"2009","journal-title":"Surg Neurol"},{"key":"10.1016\/j.arcped.2014.01.005_bib0095","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0899-7071(03)00121-9","article-title":"Sickle cell cerebrovascular disease: usual and unusual findings on MR imaging and MR angiography","volume":"28","author":"Moritani","year":"2004","journal-title":"Clin Imaging"},{"key":"10.1016\/j.arcped.2014.01.005_bib0100","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3171\/jns.1991.75.3.0356","article-title":"Intracranial aneurysms in sickle-cell anemia: clinical features and pathogenesis","volume":"75","author":"Oyesiku","year":"1991","journal-title":"J Neurosurg"},{"key":"10.1016\/j.arcped.2014.01.005_bib0105","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/S0140-6736(00)04821-2","article-title":"Nocturnal hypoxaemia and central-nervous-system events in sickle-cell disease","volume":"357","author":"Kirkham","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2014.01.005_bib0110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00277-010-1048-4","article-title":"Cost-effectiveness of adenotonsillectomy in reducing obstructive sleep apnea, cerebrovascular ischemia, vaso-occlusive pain, and ACS episodes in pediatric sickle cell disease","volume":"90","author":"Tripathi","year":"2011","journal-title":"Ann Hematol"},{"key":"10.1016\/j.arcped.2014.01.005_bib0115","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199202273260905","article-title":"The use of transcranial ultrasonography to predict stroke in sickle cell disease","volume":"326","author":"Adams","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcped.2014.01.005_bib0120","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1182\/blood-2003-06-1972","article-title":"Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study","volume":"103","author":"Abboud","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.arcped.2014.01.005_bib0125","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1067\/mpd.2001.117580","article-title":"Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease","volume":"139","author":"Miller","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.arcped.2014.01.005_bib0130","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00043426-200007000-00010","article-title":"Multicenter comparison of magnetic resonance imaging and transcranial Doppler ultrasonography in the evaluation of the central nervous system in children with sickle cell disease","volume":"22","author":"Wang","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.arcped.2014.01.005_bib0135","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1161\/STROKEAHA.107.483115","article-title":"Confirmation of an association between the TNF(-308) promoter polymorphism and stroke risk in children with sickle cell anemia","volume":"38","author":"Hoppe","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.arcped.2014.01.005_bib0140","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.1182\/blood-2011-01-332205","article-title":"Genetic predictors for stroke in children with sickle cell anemia","volume":"117","author":"Flanagan","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.arcped.2014.01.005_bib0145","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcped.2014.01.005_bib0150","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1182\/blood-2003-08-2733","article-title":"Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study","volume":"103","author":"Adams","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.arcped.2014.01.005_bib0155","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1056\/NEJMoa050460","article-title":"Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease","volume":"353","author":"Adams","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcped.2014.01.005_bib0160","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/pbc.23145","article-title":"Stroke with transfusions changing to hydroxyurea (SWiTCH): a phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload","volume":"57","author":"Ware","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.arcped.2014.01.005_bib0165","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1182\/blood-2006-11-057893","article-title":"Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia","volume":"110","author":"Zimmerman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.arcped.2014.01.005_bib0170","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood-2011-11-392340","article-title":"Stroke with transfusions changing to hydroxyurea (SWiTCH)","volume":"119","author":"Ware","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.arcped.2014.01.005_bib0175","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.neurol.2010.11.005","article-title":"Recommandations formalis\u00e9es d\u2019experts\u00a0: prise en charge de l\u2019AVC par le r\u00e9animateur. Particularit\u00e9s p\u00e9diatriques (nouveau-n\u00e9 exclu)","volume":"168","author":"Kossorotoff","year":"2012","journal-title":"Rev Neurol"},{"key":"10.1016\/j.arcped.2014.01.005_bib0180","first-page":"15","article-title":"Prevention and management of strokes in patients with sickle cell disease","volume":"5","author":"Abboud","year":"2006","journal-title":"Curr Hematol Rep"},{"key":"10.1016\/j.arcped.2014.01.005_bib0185","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0002-9343(78)90772-6","article-title":"The natural history of stroke in sickle cell disease","volume":"65","author":"Powars","year":"1978","journal-title":"Am J Med"},{"key":"10.1016\/j.arcped.2014.01.005_bib0190","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jpeds.2006.06.037","article-title":"Exchange blood transfusion compared with simple transfusion for first overt stroke is associated with a lower risk of subsequent stroke: a retrospective cohort study of 137\u00a0children with sickle cell anemia","volume":"149","author":"Hulbert","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.arcped.2014.01.005_bib0195","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0022-3476(95)70204-0","article-title":"Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions","volume":"126","author":"Pegelow","year":"1995","journal-title":"J Pediatr"},{"key":"10.1016\/j.arcped.2014.01.005_bib0200","first-page":"CD003146","article-title":"Blood transfusion for preventing stroke in people with sickle cell disease","volume":"1","author":"Riddington","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arcped.2014.01.005_bib0205","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3324\/haematol.13610","article-title":"Effect of transfusion therapy on cerebral vasculopathy in children with sickle-cell anemia","volume":"94","author":"Bader-Meunier","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.arcped.2014.01.005_bib0210","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00277-008-0670-x","article-title":"Does regular blood transfusion prevent progression of cerebrovascular lesions in children with sickle cell disease?","volume":"88","author":"Brousse","year":"2009","journal-title":"Ann Hematol"},{"key":"10.1016\/j.arcped.2014.01.005_bib0215","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1182\/blood-2010-01-261123","article-title":"Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease","volume":"117","author":"Hulbert","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.arcped.2014.01.005_bib0220","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0022-3476(05)82150-X","article-title":"High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease","volume":"118","author":"Wang","year":"1991","journal-title":"J Pediatr"},{"key":"10.1016\/j.arcped.2014.01.005_bib0225","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/pbc.24178","article-title":"Hydroxyurea for the treatment of sickle cell disease: efficacy, barriers, toxicity, and management in children","volume":"59","author":"Strouse","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.arcped.2014.01.005_bib0230","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1182\/blood-2007-03-079665","article-title":"Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease","volume":"110","author":"Bernaudin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.arcped.2014.01.005_bib0235","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.3171\/2009.01.FOCUS08307","article-title":"Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome","volume":"26","author":"Smith","year":"2009","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.arcped.2014.01.005_bib0240","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/08880010903360367","article-title":"Design of the silent cerebral infarct transfusion (SIT) trial","volume":"27","author":"Casella","year":"2010","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.arcped.2014.01.005_bib0245","first-page":"382","article-title":"Cognitive impairment in children with hemoglobin SS sickle cell disease: relationship to MR imaging findings and hematocrit","volume":"24","author":"Steen","year":"2003","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.arcped.2014.01.005_bib0250","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2141.2005.05828.x","article-title":"An exploratory study of physiological correlates of neurodevelopmental delay in infants with sickle cell anaemia","volume":"132","author":"Hogan","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.arcped.2014.01.005_bib0255","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/09297049.2011.640932","article-title":"Association between biological markers of sickle cell disease and cognitive functioning amongst Cameroonian children","volume":"19","author":"Ruffieux","year":"2013","journal-title":"Child Neuropsychol"},{"key":"10.1016\/j.arcped.2014.01.005_bib0260","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1182\/blood-2011-03-337915","article-title":"Cervical carotid artery disease in sickle cell anemia: clinical and radiological features","volume":"118","author":"Telfer","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.arcped.2014.01.005_bib0265","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1365-2141.2010.08480.x","article-title":"A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction","volume":"153","author":"Hoppe","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.arcped.2014.01.005_bib0270","doi-asserted-by":"crossref","first-page":"895","DOI":"10.2146\/ajhp090229","article-title":"Effects of antiplatelet and anticoagulant medications on the vasoocclusive and thrombotic complications of sickle cell disease: a review of the literature","volume":"67","author":"Charneski","year":"2010","journal-title":"Am J Health Syst Pharm"}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X14000268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X14000268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T13:49:09Z","timestamp":1565272149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X14000268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0929693X14000268"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2014.01.005","relation":{},"ISSN":["0929-693X"],"issn-type":[{"value":"0929-693X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dr\u00e9panocytose et atteinte vasculaire c\u00e9r\u00e9brale chez l\u2019enfant","name":"articletitle","label":"Article Title"},{"value":"Archives de P\u00e9diatrie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcped.2014.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}